# Pharmacokinetics Distribution of Raltegravir by PET/MR

> **NCT03174977** · EARLY_PHASE1 · RECRUITING · sponsor: **University of California, San Francisco** · enrollment: 10 (estimated)

## Conditions studied

- HIV-1-infection

## Interventions

- **DRUG:** 18F-Raltegravir

## Key facts

- **NCT ID:** NCT03174977
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2018-04-01
- **Primary completion:** 2024-11-01
- **Final completion:** 2025-01-01
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2024-06-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03174977

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03174977, "Pharmacokinetics Distribution of Raltegravir by PET/MR". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT03174977. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*